SANOFI BELGIUM
ActiveSANOFI BELGIUM has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €87.25M and a net result of €15.07M. Equity is shrinking by ~6.6% per year across the filed fiscal years. Its solvency ranks better than 43% of 4827 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
85
/ 100
Excellent▼ -15 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability53▼-19
Solvency77▼-22
Growth52▲+1
Stability100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity ample (current ratio 1.7 against 2.67 in 2024), but 60.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
39.9%
Return on assets
6.9%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-06-2026, 37 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
37 d early
2024
328 d late
2023
2 d late
2022
24 d early
2021
94 d late
2020
22 d early
2019
35 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€296.70M▲ 7.8%
2024 · €275.35M
2018: €250.33M
2019: €257.47M
2020: €247.18M
2021: €245.20M
2022: €235.80M
2023: €241.43M
2024: €275.35M
2018 → 2025
EBIT margin
4.8%▲ 1.0pp
2024 · 3.8%
2018: 0.3%
2019: -2.1%
2020: 9.3%
2021: 1.7%
2022: 4.6%
2023: -2.1%
2024: 3.8%
2018 → 2025
Net result
€15.07M▼ 62.7%
2024 · €40.41M
2018: €-177k
2019: €-5.02M
2020: €17.99M
2021: €2.74M
2022: €7.86M
2023: €-4.66M
2024: €40.41M
2018 → 2025
Working capital
€89.42M▼ 17.5%
2024 · €108.33M
2018: €122.98M
2019: €91.47M
2020: €110.32M
2021: €103.57M
2022: €45.40M
2023: €46.77M
2024: €108.33M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€245.20M-€235.80M▼ 3.8%€241.43M▲ 2.4%€275.35M▲ 14.1%€296.70M▲ 7.8%
Equity€121.62M-€63.43M▼ 47.8%€58.77M▼ 7.4%€99.18M▲ 68.8%€87.25M▼ 12.0%
Operating result€4.17M-€10.85M▲ 160%€-5.08M€10.46M€14.21M▲ 36.0%
Net result€2.74M-€7.86M▲ 187%€-4.66M€40.41M€15.07M▼ 62.7%
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 36% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €218.90M
Fixed assets
€1.15M▲ 121%
Current assets
€217.75M▲ 25.8%
Equity and liabilities €218.90M
Equity
€87.25M▼ 12.0%
Provisions
€3.33M▼ 65.5%
Debt
€128.33M▲ 98.1%
The debt ratio rises from 37.3% to 58.6%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€14.43M▲
2024 · €10.72M
Cash flow
€15.28M▼
2024 · €40.67M
Solvency
39.9%▼
2024 · 57.1%
Current ratio
1.70▼
2024 · 2.67
Quick ratio
1.25▼
2024 · 1.82
Debt / equity
1.47▲
2024 · 0.65
ROE
17.3%▼
2024 · 40.7%
ROA
6.9%▼
2024 · 23.3%
Interest coverage
25057.80▲
2024 · 6461.92
Debt
€128.33M▲
2024 · €64.76M
Debt ≤ 1 year
€128.33M▲
2024 · €64.74M
Income taxes
€864k▼
2024 · €4.08M
Staff costs
€40.80M▼
2024 · €52.26M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€173.60M€218.90M▲
Fixed assets21/28€520k€1.15M▲
Tangible fixed assets22/27€516k€1.15M▲
Plant, machinery and equipment23€102k€32k▼
Furniture and vehicles24€275k€417k▲
Other tangible fixed assets26€29k€698k▲
Assets under construction and advance payments27€110k€0▼
Financial fixed assets28€4k€4k=
Other financial fixed assets284/8€4k€4k=
Amounts receivable and cash guarantees285/8€4k€4k=
Current assets29/58€173.07M€217.75M▲
Stocks and contracts in progress3€54.99M€57.31M▲
Stocks30/36€54.99M€57.31M▲
Raw materials and consumables30/31€190k€103k▼
Finished goods33€0-
Goods purchased for resale34€54.80M€57.20M▲
Amounts receivable within one year40/41€108.23M€159.80M▲
Trade receivables40€45.71M€49.58M▲
Other amounts receivable41€62.52M€110.22M▲
Cash at bank and in hand54/58€4k€0▼
Deferred charges and accrued income490/1€9.85M€647k▼
Equity and liabilities
Total equity and liabilities10/49€173.60M€218.90M▲
Equity10/15€99.18M€87.25M▼
Contributions10/11€45.61M€45.61M=
Capital10€45.57M€45.57M=
Issued capital100€45.57M€45.57M=
Outside capital11€43k€43k=
Share premium1100/10€43k€43k=
Reserves13€9.97M€9.97M=
Non-distributable reserves130/1€5.02M€5.02M=
Legal reserve130€5.01M€5.01M=
Reserves not available under the articles1311€8k€8k=
Tax-exempt reserves132€4.28M€4.28M=
Distributable reserves133€662k€662k=
Profit (loss) carried forward14€43.60M€31.67M▼
Provisions and deferred taxes16€9.66M€3.33M▼
Provisions for liabilities and charges160/5€9.66M€3.33M▼
Pensions and similar obligations160€9.61M€2.79M▼
Other liabilities and charges164/5€46k€536k▲
Amounts payable17/49€64.76M€128.33M▲
Amounts payable within one year42/48€64.74M€128.33M▲
Trade debts44€47.78M€105.11M▲
Suppliers440/4€47.78M€105.11M▲
Taxes, remuneration and social security45€10.85M€16.02M▲
Taxes450/3€130k€5.37M▲
Remuneration and social security454/9€10.72M€10.66M▼
Other amounts payable47/48€6.11M€7.20M▲
Accrued charges and deferred income492/3€21k€0▼
Income statement
Code20242025
Operating income70/76A€292.72M€319.06M▲
Turnover70€275.35M€296.70M▲
Other operating income74€17.37M€22.37M▲
Operating charges60/66A€282.26M€304.85M▲
Goods for resale, raw materials and consumables60€175.77M€216.31M▲
Purchases600/8€185.02M€221.41M▲
Change in stocks: decrease (increase)609€-9.25M€-5.10M▲
Services and other goods61€17.25M€19.32M▲
Remuneration, social security and pensions62€52.26M€40.80M▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€260k€211k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€4.42M€1.43M▼
Provisions for liabilities and charges: additions (uses and reversals)635/8€137k€20k▼
Other operating charges640/8€31.71M€26.30M▼
Non-recurring operating charges66A€464k€459k▼
Operating profit (loss)9901€10.46M€14.21M▲
Financial income75/76B€34.05M€1.74M▼
Recurring financial income75€1.57M€1.74M▲
Other financial income752/9€1.57M€1.74M▲
Non-recurring financial income76B€32.48M-
Financial charges65/66B€17k€18k▲
Recurring financial charges65€17k€18k▲
Debt charges650€2k€576▼
Other financial charges652/9€15k€17k▲
Profit (loss) for the period before taxes9903€44.49M€15.94M▼
Income taxes67/77€4.08M€864k▼
Taxes670/3€4.08M€864k▼
Profit (loss) for the period9904€40.41M€15.07M▼
Profit (loss) for the period to be appropriated9905€40.41M€15.07M▼
Appropriation of the result
Profit (loss) to be appropriated9906€43.60M€58.67M▲
Profit (loss) brought forward from the previous period14P€3.19M€43.60M▲
Profit to be distributed694/7-€27.00M
Return on contributions (dividend)694-€27.00M
Social balance
Average headcount (FTE)9087203.9185.5▼
The notes to these accounts (55 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
24-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 328 days late
2024
31-12
Financial
Back to profitnet €40.41M
Net result €40.41M after one loss-making year.
23-08
State Gazette act
General meeting · Board meeting
Director appointment · Director reappointment
23-08
State Gazette act
General meeting · Director appointment
Director reappointment · Director resignation
02-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 2 days late
2023
07-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
11-05
State Gazette act
General meeting · Director reappointment
Auditor appointment · Permanent representative
11-05
State Gazette act
General meeting · Director reappointment
Auditor appointment · Permanent representative
2022
02-11
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 94 days late
2021
09-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Back to profitnet €17.99M
Net result €17.99M after 2 loss-making years.
22-07
State Gazette act
Board meeting · General meeting
Director resignation · Director appointment
22-07
State Gazette act
Board meeting · Director resignation
Director appointment · Permanent representative
26-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Weakest financial yearnet €-5.02M
Net result drops to €-5.02M, the lowest in the series; recovery starts the following year.
20-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
14-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
16-08
State Gazette act
General meeting · Director appointment
Director reappointment
16-08
State Gazette act
General meeting · Director appointment
Director reappointment
04-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
2011
03-05
State Gazette act
General meeting · Director appointment
Director reappointment · Director resignation
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
90 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Machelen (Brab.) · 2 establishment units since 1998
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Leonardo da Vincilaan 191831 Machelen (Brab.)Ground area
1,965 m²
Building footprint
1,809 m²
Volume, LiDAR
41,182 m³
2 parcels, Brussels, Flanders · tallest building 34.8 m, ±9 floors. Linked by address, not a title deed.
2 establishment units
Leonardo da Vincilaan 19, 1831 Machelen (Brab.)
since 19982.089.115.328
Sanofi Belgium
since 20052.222.809.438
2 parcels
Flanders
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21805E0405/00G000indicative | Brussels | 1,804 m² | 1 · 1,809 m² | 34.8 m · 9 fl. |
| 23015B0320/00D000indicative | Flanders | 161 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
0 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Structure & network
Ownership & control
1 partySANOFI BELGIUMBE 0464.435.901
controls
Where this company holds controlthis company sits on their board1
Group per the LEI register
1 parent companyParent company:SANOFI
Public money · subsidies and aid
Flemish government
2022 to 2025 · 4 entries · 9,542 EUR awarded · 9,542 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 2,556 EUR | 2,556 EUR |
| 2024 | 1 | 170 EUR | 170 EUR |
| 2023 | 1 | 6,560 EUR | 6,560 EUR |
| 2022 | 1 | 256 EUR | 256 EUR |
Schemes
Vlaams opleidingsverlof (VOV)
Recognitions · licences · registrations
Legal Entity Identifier
549300R1WE1M15K65C96
Similar companies · same sector, comparable size
GMED HEALTHCARE
BE 0822.358.674
Machelen (Brab.) · Eq €85.08M
ECUPHAR
BE 0476.255.350
Oostkamp · Eq €83.29M
ANSELL HEALTHCARE EUROPE
BE 0437.593.328
Anderlecht · Eq €93.52M
JOHNSON & JOHNSON MEDICAL
BE 0425.967.580
Machelen (Brab.) · Eq €80.17M
OMEGA PHARMA INTERNATIONAL
BE 0807.596.363
Gent · Eq €95.40M
Of 1,894 companies in sector 46460 we hold annual accounts for 1,114. 129 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded27-10-1998
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
51180
46180Agents specialised in the wholesale of other particular products
Sources
Crossroads Bank for EnterprisesNational Bank · 27 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.